Preproposal deadline: July 21, 2026 Specific requirements for Canadian applicants are now available on ResearchNet: Canadian Institutes of Health Research | Instituts de recherche en sant du Canada To view or add a comment, sign in Launched: TRANSCAN-4 JTC 2026 Translational Research on Cancer Metabolism: Multidisciplinary Approaches for Diagnosis and Treatment CIHR and the Cancer Research Society are partnering to support Canadian researchers in this call, which aims to support the development of innovative, personalized approaches for cancer diagnosis, patient stratification, and treatment, grounded in a deeper mechanistic understanding of metabolic alterations in cancer
Recently, as the function of IGFs has gradually been revealed, the important role that IGFs play in cancer progression has brought new hope for cancer treatment
Duloxetine: Originally used as an antidepressant, duloxetine has been shown to relieve neuropathic pain
The CAS number for GHK-Cu is 89030-95-5 (GHK-Cu complex)
2.2 Oxidative stress in major depressive disorder According to the World Health Organization (WHO), MDD was the fourth leading cause of disability worldwide and was predicted to rise to second by 2020
In laboratory settings, researchers use GHK-Cu as a model compound to study tissue remodeling, extracellular matrix (ECM) regulation, copper handling, and redox (oxidation-reduction) signaling
